
Hanoi (VNA) – Vietnam is expected to get 31 million COVID-19 vaccine doses developed by
US-based firm Pfizer in the third and fourth quarters of 2021, said the Ministry of Health (MoH).
The MoH and relevant agencies have taken measures to accelerating negotiations
towards signing an agreement on the purchase
of Pfizer in line with the vaccine supply roadmap discussed and
agreed by the two sides.
According to Heath Minister Nguyen Thanh Long, the ministry has coordinated
with the Government Office, the Ministry of Planning and Investment, and the
Ministry of Justice, to consult Cabinet members on the purchase of Pfizer
vaccine, and prepare for the signing of an agreement with Pfizer to buy 31
million doses as soon as possible.
The negotiation process for this agreement has been continuously promoted by
the MoH during the past time, focusing on terms related to liability, payment,
reimbursement and risks when implementing the agreement on the principle of
ensuring compliance with the law of and international law.
In recent times, the MoH has also continuously negotiated with many COVID-19
vaccine manufacturers such as Astra Zeneca, Moderna, Gamelaya with the goal of
having enough COVID-19 vaccines to serve the
locals.
It is also working with foreign partners on transfer of vaccine production technologies
to Vietnam.
Vietnam began its COVID-19 inoculation drive on March 8, using the AstraZeneca vaccine of the UK. More than one million COVID-19 vaccine shots were
given to frontline medical workers and members of community-based anti-
groups in the country as of 4pm on May 18.
Currently, four Vietnamese vaccines are under development, produced by Nagogen
Pharmaceutical Biotechnology JSC, the Institute of Vaccines and Medical
Biologicals (IVAC), Vaccine and Biological Production Company No. 1 (Vabiotech)
and the Center for Research and Production of Vaccines and Biologicals
(Polyvac)./.
Source: VietnamPlus